Paraplegin

Paraplegin is a protein that in humans is encoded by the SPG7 gene located on chromosome 16.[4][5][6]

SPG7
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesSPG7, CAR, CMAR, PGN, SPG5C, paraplegin matrix AAA peptidase subunit, SPG7 matrix AAA peptidase subunit, paraplegin
External IDsOMIM: 602783 MGI: 2385906 HomoloGene: 31133 GeneCards: SPG7
Gene location (Human)
Chr.Chromosome 16 (human)[1]
Band16q24.3Start89,490,719 bp[1]
End89,557,768 bp[1]
RNA expression pattern


More reference expression data
Orthologs
SpeciesHumanMouse
Entrez

6687

234847

Ensembl

ENSG00000197912

n/a

UniProt

Q9UQ90

Q3ULF4

RefSeq (mRNA)

NM_003119
NM_199367
NM_001363850

NM_153176
NM_001364435

RefSeq (protein)

NP_003110
NP_955399
NP_001350779

NP_694816
NP_001351364

Location (UCSC)Chr 16: 89.49 – 89.56 Mbn/a
PubMed search[2][3]
Wikidata
View/Edit HumanView/Edit Mouse

Structure

The SPG7 gene contains 21 exons and encodes for a protein that is approximately 88 kDa in size. Two transcript variants encoding distinct isoforms have been identified for this gene.

The structure of the SPG7 resolved by X-ray crystallography reveals that the protein functions as a hexamer and is structurally most similar to bacterial FtSH proteases. It contains an FtsH-homology protease domain as well as an AAA+ homology ATPase domain. The protein is thought to use ATPase-driven conformational changes to the AAA-domain in order to deliver the substrate peptides to be degraded to its protease core.[7]

Function

The SPG7 protein is a nuclear-encoded metalloprotease protein that is a member of the AAA protein family. Members of this protein family share an ATPase domain and have roles in diverse cellular processes including membrane trafficking, intracellular motility, organelle biogenesis, protein folding, and proteolysis. The SPG7 protein is a transmembrane protein that is located to the inner mitochondrial membrane, and is part of the m-AAA metalloproteinase complex, which constitutes one of the known intra-mitochondrial proteases that function in mitochondrial protein quality control.

Interactions

SPG7 interacts with AFG like AAA ATPase 2 (AFG3L2) on the mitochondrial inner membrane to form the m-AAA metalloproteinase complex.

Clinical significance

Mutations associated with this gene cause autosomal recessive spastic paraplegia 7, a neurodegenerative disorder that is characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. SPG7 mutations have also been associated with other undiagnosed ataxia.[8][9][10]

In model animals, knockdown of spastic paraplegia 7 by siRNA inhibits the early stages of HIV-1 replication in 293T cells infected with VSV-G pseudotyped HIV-1.[11] It has been shown that an SPG7 variant escapes phosphorylation-regulated processing by AFG3L2 and increases mitochondrial reactive oxygen species generation and is correlated with many clinical phenotypes.[12] Furthermore, SPG7 deficiency is associated with abnormal mitochondrial DNA maintenance, which may lead to secondary mitochondrial DNA lesions and impaired respiratory activities and mitochondrial functions.[13]

gollark: ++tel link discord 828679749433032724 no
gollark: This is actually incorrect.
gollark: As in, I don't do much? There isn't much activity shown for you either. Helpers cannot do much moderatey stuff.
gollark: This is actually wrong and bad.
gollark: I can understand things without agreeing with them.

References
  1. GRCh38: Ensembl release 89: ENSG00000197912 - Ensembl, May 2017
  2. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  3. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. Casari G, De Fusco M, Ciarmatori S, Zeviani M, Mora M, Fernandez P, De Michele G, Filla A, Cocozza S, Marconi R, Dürr A, Fontaine B, Ballabio A (Jun 1998). "Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease". Cell. 93 (6): 973–83. doi:10.1016/S0092-8674(00)81203-9. PMID 9635427.
  5. De Michele G, De Fusco M, Cavalcanti F, Filla A, Marconi R, Volpe G, Monticelli A, Ballabio A, Casari G, Cocozza S (Jul 1998). "A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3". American Journal of Human Genetics. 63 (1): 135–9. doi:10.1086/301930. PMC 1377251. PMID 9634528.
  6. "Entrez Gene: SPG7 spastic paraplegia 7, paraplegin (pure and complicated autosomal recessive)".
  7. Karlberg T, van den Berg S, Hammarström M, Sagemark J, Johansson I, Holmberg-Schiavone L, Schüler H (2009). "Crystal structure of the ATPase domain of the human AAA+ protein paraplegin/SPG7". PLoS ONE. 4 (10): e6975. doi:10.1371/journal.pone.0006975. PMC 2734466. PMID 19841671.
  8. Pfeffer G, Pyle A, Griffin H, Miller J, Wilson V, Turnbull L, Fawcett K, Sims D, Eglon G, Hadjivassiliou M, Horvath R, Németh A, Chinnery PF (2015). "SPG7 mutations are a common cause of undiagnosed ataxia". Neurology. 84 (11): 1174–6. doi:10.1212/WNL.0000000000001369. PMC 4371411. PMID 25681447.
  9. Warnecke T, Duning T, Schirmacher A, Mohammadi S, Schwindt W, Lohmann H, Dziewas R, Deppe M, Ringelstein EB, Young P (2010). "A novel splice site mutation in the SPG7 gene causing widespread fiber damage in homozygous and heterozygous subjects". Mov. Disord. 25 (4): 413–20. doi:10.1002/mds.22949. PMID 20108356.
  10. Casari G, De Fusco M, Ciarmatori S, Zeviani M, Mora M, Fernandez P, De Michele G, Filla A, Cocozza S, Marconi R, Dürr A, Fontaine B, Ballabio A (1998). "Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease". Cell. 93 (6): 973–83. doi:10.1016/s0092-8674(00)81203-9. PMID 9635427.
  11. König R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, et al. (Oct 2008). "Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication". Cell. 135 (1): 49–60. doi:10.1016/j.cell.2008.07.032. PMC 2628946. PMID 18854154.
  12. Almontashiri NA, Chen HH, Mailloux RJ, Tatsuta T, Teng AC, Mahmoud AB, Ho T, Stewart NA, Rippstein P, Harper ME, Roberts R, Willenborg C, Erdmann J, Pastore A, McBride HM, Langer T, Stewart AF (2014). "SPG7 variant escapes phosphorylation-regulated processing by AFG3L2, elevates mitochondrial ROS, and is associated with multiple clinical phenotypes". Cell Rep. 7 (3): 834–47. doi:10.1016/j.celrep.2014.03.051. PMID 24767997.
  13. Pfeffer G, Gorman GS, Griffin H, Kurzawa-Akanbi M, Blakely EL, Wilson I, Sitarz K, Moore D, Murphy JL, Alston CL, Pyle A, Coxhead J, Payne B, Gorrie GH, Longman C, Hadjivassiliou M, McConville J, Dick D, Imam I, Hilton D, Norwood F, Baker MR, Jaiser SR, Yu-Wai-Man P, Farrell M, McCarthy A, Lynch T, McFarland R, Schaefer AM, Turnbull DM, Horvath R, Taylor RW, Chinnery PF (2014). "Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance". Brain. 137 (Pt 5): 1323–36. doi:10.1093/brain/awu060. PMC 3999722. PMID 24727571.

Further reading
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.